Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Prognostic Impact of the Latency Time from the Administration of Cytotoxic Therapy to the Development of Therapy-Related Myeloid Neoplasms

Claudia Nunez-Torron, MD, Adolfo Saez, Berta Mercedes Michael Fernández, Irene Garcia-Garcia, Juan Marquet Palomanes, Miguel Piris-Villaespesa, MD, Jesus Villarrubia, PhD, Valentín Garcia-Gutiérrez, MD PhD, Gemma Moreno Jiménez, MD, Javier Lopez Jimenez, MD PhD, Pilar Herrera Puente

Blood (2020) 136 (Supplement 1): 34–35.

https://doi.org/10.1182/blood-2020-141907

Published: 2020

Journal Articles

Survival Analysis According to Minimal Residual Disease By Flow Cytometry in Acute Myeloid Leukemia after First Induction

Claudia Nunez-Torron, MD, Juan Marquet Palomanes, MD, Fernando Martín Moro, Adolfo Saez-Martin, MD, Alejandro Luna, MD, Irene Garcia-Garcia, Berta Mercedes Michael Fernández, Jesus Villarrubia, PhD, Miguel Piris-Villaespesa, MD, Ernesto Roldan Santiago, Eulalia Rodríguez Martín, Gemma Moreno, MD, Valentín García Gutiérrez, PhD, Javier Lopez Jimenez, MD PhD, Pilar Herrera Puente

Blood (2019) 134 (Supplement_1): 1433.

https://doi.org/10.1182/blood-2019-130190

Published: 2019

Journal Articles

Diffuse Large B-Cell Lymphoma, Not Otherwise Specified: Discordance between Histology and Flow Cytometry in Bone Marrow Examination at Diagnosis

Fernando Martín Moro, Miguel Piris-Villaespesa, Monica Garcia Cosio, MD, Jesus Villarrubia, PhD, Juan Marquet Palomanes, MD, Ana Lario Arribas, MD, Eulalia Rodríguez Martín, María Calbacho, MD, Irene Garcia-Garcia, Berta Mercedes Michael Fernández, Carla Martínez-Geijo Román, Kyra Velázquez-Kennedy, Alejandro Sanz, Pilar Herrera Puente, Gemma Moreno Jiménez, Jose Valentín García Gutiérrez, MD PhD, Javier Lopez Jimenez, MD PhD

Blood (2018) 132 (Supplement 1): 1718.

https://doi.org/10.1182/blood-2018-99-117041

Published: 2018

Journal Articles

Deregulation of TLR2-JMJD3 Innate Immunity Signaling, Including a Rare TLR2 SNP As a Potential Somatic Mutation, in Myelodysplastic Syndromes (MDS)

Yue Wei, PhD, Rui Chen, Sophie Dimicoli, MD, PhD, Carlos E. Bueso-Ramos, MD, PhD, Donna S. Neuberg, ScD, Sherry A. Pierce, RN, BS, Hui Yang, MD, PhD., Yu Jia, Hong Zheng, Zhihong Fang, Martin Nguyen, Michael Fernandez, Sa A. Wang, MD, Hagop M. Kantarjian, MD, Guillermo Garcia-Manero, MD

Blood (2012) 120 (21): 1700.

https://doi.org/10.1182/blood.V120.21.1700.1700

Published: 2012

Journal Articles

Serum Amyloid Protein A 1 (hSAA1) Is Overexpressed in Myelodysplastic Syndromes and Potentially Mediates Toll-Like Receptor 2 Innate Immunity Signaling in CD34+ Hematopoietic Stem Cells

Yue Wei, PhD, Carlos E. Bueso-Ramos, MD, PhD, Hui Yang, MD, PhD., Yu Jia, Hong Zheng, Simona Colla, Martin Nguyen, Michael Fernandez, Hagop M. Kantarjian, MD, Guillermo Garcia-Manero, MD

Blood (2012) 120 (21): 1703.

https://doi.org/10.1182/blood.V120.21.1703.1703

Published: 2012

Journal Articles

Toll-Like Receptor (TLR) Signaling Adaptor Protein MYD88 in Myelodysplastic Syndromes (MDS)

Sophie Dimicoli, MD, PhD, Yue Wei, PhD, Rui Chen, Carlos E. Bueso-Ramos, MD, PhD, Sherry A. Pierce, RN, BS, Hui Yang, MD, PhD., Yu Jia, Hong Zheng, Zhihong Fang, Irene ganan-Gomez, Martin Nguyen, Michael Fernandez, Hagop M. Kantarjian, MD, Guillermo Garcia-Manero, MD

Blood (2012) 120 (21): 556.

https://doi.org/10.1182/blood.V120.21.556.556

Published: 2012

Journal Articles

Induction of PD-1 and PD-1 Ligand Expression by Hypomethylating Agents (HMA) in Myelodysplastic Syndromes and Acute Myelogenous Leukemia Suggest a Role for T Cell Function in Clinical Resistance to Hmas

Hui Yang, MD, PhD., Carlos E. Bueso-Ramos, MD, PhD, Simrit Parmar, M.D., Yue Wei, PhD, Zhihong Fang, Martin Nguyen, Michael Fernandez, Sherry A. Pierce, RN, BS, Qirong Geng, Hagop M. Kantarjian, MD, Jorge E Cortes, MD, Guillermo Garcia-Manero, MD

Blood (2012) 120 (21): 3810.

https://doi.org/10.1182/blood.V120.21.3810.3810

Published: 2012

Journal Articles

Genome-Wide Chip-Seq Analysis of Histone Methylation Reveals Modulators of NF-κB Signaling and the Histone Demethylase JMJD3 as Implicated in Disease Progression in Myelodysplastic Syndrome (MDS).

Yue Wei, PhD, Rui Chen, PhD, Carlos E. Bueso-Ramos, MD, Hui Wang, PhD, Xingzhi Song, PhD, Jing Wang, Hui Yao, Martin Nguyen, Michael Fernandez, Hui Yang, MD, PhD, Guillermo Garcia-Manero, MD

Blood (2009) 114 (22): 291.

https://doi.org/10.1182/blood.V114.22.291.291

Published: 2009

Journal Articles

Epigenetic Silencing of the RUNX3 Gene by Promoter Hypermethylation in Patients with Acute Myeloid Leukemia.

Sirisha C Maddipoti, M.D., Carlos Bueso-Ramos, MD, Hui Yang, MD, PhD, Michael Fernandez, Shaoquing Kuang, MD, PhD, Zihong Fang, PhD, William Stevenson, MD, Yue Wei, PhD, Sherry Pierce, RN, Guillermo Garcia-Manero, MD

Blood (2008) 112 (11): 3341.

https://doi.org/10.1182/blood.V112.11.3341.3341

Published: 2008

Journal Articles

Thrombin-Releasable Protein Z-Dependent Protease Inhibitor Identified in Platelets and Is Likely Due to Uptake from Plasma.

Xin Han, MD, Martin H. Nguyen, Michael Fernandez, George J. Broze, M.D., Carlos E. Bueso-Ramos, M.D., Ph.D.

Blood (2007) 110 (11): 1751.

https://doi.org/10.1182/blood.V110.11.1751.1751

Published: 2007

NARROW

Prognostic Impact of the Latency Time from the Administration of Cytotoxic Therapy to the Development of Therapy-Related Myeloid Neoplasms

Survival Analysis According to Minimal Residual Disease By Flow Cytometry in Acute Myeloid Leukemia after First Induction

Diffuse Large B-Cell Lymphoma, Not Otherwise Specified: Discordance between Histology and Flow Cytometry in Bone Marrow Examination at Diagnosis

Deregulation of TLR2-JMJD3 Innate Immunity Signaling, Including a Rare TLR2 SNP As a Potential Somatic Mutation, in Myelodysplastic Syndromes (MDS)

Serum Amyloid Protein A 1 (hSAA1) Is Overexpressed in Myelodysplastic Syndromes and Potentially Mediates Toll-Like Receptor 2 Innate Immunity Signaling in CD34+ Hematopoietic Stem Cells

Toll-Like Receptor (TLR) Signaling Adaptor Protein MYD88 in Myelodysplastic Syndromes (MDS)

Induction of PD-1 and PD-1 Ligand Expression by Hypomethylating Agents (HMA) in Myelodysplastic Syndromes and Acute Myelogenous Leukemia Suggest a Role for T Cell Function in Clinical Resistance to Hmas

Genome-Wide Chip-Seq Analysis of Histone Methylation Reveals Modulators of NF-κB Signaling and the Histone Demethylase JMJD3 as Implicated in Disease Progression in Myelodysplastic Syndrome (MDS).

Epigenetic Silencing of the RUNX3 Gene by Promoter Hypermethylation in Patients with Acute Myeloid Leukemia.

Thrombin-Releasable Protein Z-Dependent Protease Inhibitor Identified in Platelets and Is Likely Due to Uptake from Plasma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only